The global market for Vascular Closure Devices is estimated at US$875.2 Million in 2023 and is projected to reach US$1.4 Billion by 2030, growing at a CAGR of 7.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the vascular closure devices market is driven by several factors, including the rising prevalence of cardiovascular diseases globally, which increases the demand for interventional procedures requiring VCDs. Technological advancements that enhance the safety and efficacy of these devices also contribute to market expansion. Additionally, the growing preference for minimally invasive surgeries among both patients and healthcare providers boosts the adoption of VCDs.
The market is further supported by the increasing number of elderly populations, who are more prone to vascular diseases and benefit significantly from the quick recovery times associated with VCDs. Moreover, healthcare providers' emphasis on reducing procedure times and improving operational efficiencies continues to drive the adoption of advanced vascular closure technologies.
The growth in the vascular closure devices market is driven by several factors, including the rising prevalence of cardiovascular diseases globally, which increases the demand for interventional procedures requiring VCDs. Technological advancements that enhance the safety and efficacy of these devices also contribute to market expansion. Additionally, the growing preference for minimally invasive surgeries among both patients and healthcare providers boosts the adoption of VCDs.
The market is further supported by the increasing number of elderly populations, who are more prone to vascular diseases and benefit significantly from the quick recovery times associated with VCDs. Moreover, healthcare providers' emphasis on reducing procedure times and improving operational efficiencies continues to drive the adoption of advanced vascular closure technologies.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Passive Approximators segment, which is expected to reach US$996.3 Million by 2030 with a CAGR of a 8.1%. The Active Approximators segment is also set to grow at 6.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $361.3 Million in 2023, and China, forecasted to grow at an impressive 8.8% CAGR to reach $154.0 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Vascular Closure Devices Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vascular Closure Devices Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Vascular Closure Devices Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Cardinal Health, Inc., Terumo Corporation, W. L. Gore & Associates, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 36 Featured):
- Cardinal Health, Inc.
- Terumo Corporation
- W. L. Gore & Associates, Inc.
- Teleflex, Inc.
- Cordis, a Cardinal Health company
- Merit Medical Systems, Inc.
- Elixir Medical Corporation
- Tricol Biomedical, Inc.
- Marine Polymer Technologies, Inc.
- Axio Biosolutions Private Limited
- Endocor GmbH
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cardinal Health, Inc.
- Terumo Corporation
- W. L. Gore & Associates, Inc.
- Teleflex, Inc.
- Cordis, a Cardinal Health company
- Merit Medical Systems, Inc.
- Elixir Medical Corporation
- Tricol Biomedical, Inc.
- Marine Polymer Technologies, Inc.
- Axio Biosolutions Private Limited
- Endocor GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 477 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 875.2 Million |
| Forecasted Market Value ( USD | $ 1400 Million |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
